Published in J Virol Methods on February 15, 2007
Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther (2009) 0.88
Manufacturing of AcMNPV baculovirus vectors to enable gene therapy trials. Mol Ther Methods Clin Dev (2016) 0.87
High-titer preparation of Bombyx mori nucleopolyhedrovirus (BmNPV) displaying recombinant protein in silkworm larvae by size exclusion chromatography and its characterization. BMC Biotechnol (2009) 0.80
Purification of functional baculovirus particles from silkworm larval hemolymph and their use as nanoparticles for the detection of human prorenin receptor (PRR) binding. BMC Biotechnol (2011) 0.75
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res (2002) 6.64
Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol Bioeng (2003) 1.18
Characterization of yeastolate fractions that promote insect cell growth and recombinant protein production. Cytotechnology (2007) 1.06
Improving glucose and glutamine metabolism of human HEK 293 and Trichoplusia ni insect cells engineered to express a cytosolic pyruvate carboxylase enzyme. Biotechnol Prog (2003) 1.04
Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol Prog (2005) 1.03
Production of adenovirus vector for gene therapy. Biotechnol Adv (2003) 1.03
Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng (2007) 1.02
Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J Virol (2007) 1.01
Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol (2006) 0.99
Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. J Virol Methods (2007) 0.99
Quantitation of baculovirus particles by flow cytometry. J Virol Methods (2002) 0.98
Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine (2010) 0.97
High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnol Prog (2004) 0.97
Purification of recombinant proteins from mammalian cell culture using a generic double-affinity chromatography scheme. Protein Expr Purif (2005) 0.96
Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng (2004) 0.94
Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol Prog (2006) 0.93
Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII. BMC Biotechnol (2011) 0.92
Effect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystals. ACS Appl Mater Interfaces (2010) 0.92
Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol Adv (2006) 0.91
Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media. Hum Gene Ther (2009) 0.90
Development of a simple and high-yielding fed-batch process for the production of influenza vaccines. Vaccine (2009) 0.90
Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol (2011) 0.89
Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J Virol Methods (2006) 0.88
A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol Bioeng (2005) 0.88
Insights into the central metabolism of Spodoptera frugiperda (Sf-9) and Trichoplusia ni BTI-Tn-5B1-4 (Tn-5) insect cells by radiolabeling studies. Biotechnol Prog (2005) 0.87
Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. J Gene Med (2009) 0.86
Analysis of baculovirus aggregates using flow cytometry. J Virol Methods (2005) 0.86
Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum Gene Ther (2003) 0.85
New protocol for lentiviral vector mass production. Methods Mol Biol (2010) 0.84
Production and formulation of adenovirus vectors. Adv Biochem Eng Biotechnol (2005) 0.84
Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess Biosyst Eng (2010) 0.83
Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. J Virol Methods (2005) 0.83
Probing inhibitory effects of Antrodia camphorata isolates using insect cell-based impedance spectroscopy: inhibition vs chemical structure. Chem Res Toxicol (2008) 0.82
Micro-quantitation of lipids in serum-free cell culture media: a critical aspect is the minimization of interference from medium components and chemical reagents. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.82
Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnol Bioeng (2006) 0.81
Recombinant protein production in large-scale agitated bioreactors using the baculovirus expression vector system. Methods Mol Biol (2007) 0.81
Probing inhibitory effects of nanocrystalline cellulose: inhibition versus surface charge. Nanoscale (2012) 0.81
An efficient process for the purification of helper-dependent adenoviral vector and removal of helper virus by iodixanol ultracentrifugation. J Virol Methods (2010) 0.80
Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.80
Virus-like particle and viral vector production using the baculovirus expression vector system/insect cell system: adeno-associated virus-based products. Methods Mol Biol (2007) 0.79
A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. Int J Nanomedicine (2012) 0.79
Validation of a high-performance liquid chromatographic assay for the quantification of Reovirus particles type 3. J Pharm Biomed Anal (2007) 0.79
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss. BMC Biotechnol (2014) 0.78
Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures. Biotechnol Adv (2004) 0.77
Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures. Biotechnol Prog (2012) 0.77
Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3). Vaccine (2011) 0.76
Purification of retrovirus particles using heparin affinity chromatography. Methods Mol Biol (2008) 0.76
Rapid and reliable quantification of reovirus type 3 by high performance liquid chromatography during manufacturing of Reolysin. J Pharm Biomed Anal (2008) 0.76
High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.76
Evaluation of homogeneity and genetic stability of REOLYSIN (pelareorep) by complete genome sequencing of reovirus after large scale production. Appl Microbiol Biotechnol (2014) 0.76
Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions. J Virol Methods (2008) 0.76
Probing inhibitory effects of destruxins from Metarhizium anisopliae using insect cell based impedance spectroscopy: inhibition vs chemical structure. Analyst (2009) 0.75
Hyperosmotic pressure on HEK 293 cells during the growth phase, but not the production phase, improves adenovirus production. J Biotechnol (2011) 0.75
A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus. Biotechnol Bioeng (2007) 0.75
Reassessing culture media and critical metabolites that affect adenovirus production. Biotechnol Prog (2010) 0.75